Ali Z Fadhel
Examiner (ID: 9147, Phone: (571)270-0267 , Office: P/1772 )
Most Active Art Unit | 1772 |
Art Unit(s) | 1772 |
Total Applications | 589 |
Issued Applications | 422 |
Pending Applications | 57 |
Abandoned Applications | 110 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18221775
[patent_doc_number] => 20230060769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE URINARY AND PROSTATE FUNCTION IN A HUMAN
[patent_app_type] => utility
[patent_app_number] => 17/818011
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818011 | COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE URINARY AND PROSTATE FUNCTION IN A HUMAN | Aug 7, 2022 | Pending |
Array
(
[id] => 18018856
[patent_doc_number] => 20220370355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Lapatinib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/812479
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812479 | Lapatinib particles and uses thereof | Jul 13, 2022 | Issued |
Array
(
[id] => 17836222
[patent_doc_number] => 20220273527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Pouches Comprising Oral Care Active Agents
[patent_app_type] => utility
[patent_app_number] => 17/745923
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745923 | Pouches Comprising Oral Care Active Agents | May 16, 2022 | Pending |
Array
(
[id] => 18603362
[patent_doc_number] => 11744802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Therapeutic compositions for treatment of human immunodeficiency virus
[patent_app_type] => utility
[patent_app_number] => 17/738803
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29562
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738803 | Therapeutic compositions for treatment of human immunodeficiency virus | May 5, 2022 | Issued |
Array
(
[id] => 18250955
[patent_doc_number] => 20230077994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE IN A DISPENSER
[patent_app_type] => utility
[patent_app_number] => 17/719912
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719912 | ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE IN A DISPENSER | Apr 12, 2022 | Pending |
Array
(
[id] => 18018824
[patent_doc_number] => 20220370323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => CROSS LINKED SILK-HYALURONIC ACID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/713069
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713069 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | Apr 3, 2022 | Abandoned |
Array
(
[id] => 19338145
[patent_doc_number] => 12048313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health
[patent_app_type] => utility
[patent_app_number] => 17/703955
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4085
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703955 | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health | Mar 23, 2022 | Issued |
Array
(
[id] => 17881064
[patent_doc_number] => 20220296541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/691572
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691572 | N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA | Mar 9, 2022 | Pending |
Array
(
[id] => 17670820
[patent_doc_number] => 20220183987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN
[patent_app_type] => utility
[patent_app_number] => 17/685830
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685830 | PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN | Mar 2, 2022 | Pending |
Array
(
[id] => 17828446
[patent_doc_number] => 20220265750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/680970
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680970 | COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS | Feb 24, 2022 | Pending |
Array
(
[id] => 17561657
[patent_doc_number] => 20220125806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME
[patent_app_type] => utility
[patent_app_number] => 17/570194
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570194 | STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME | Jan 5, 2022 | Pending |
Array
(
[id] => 17685714
[patent_doc_number] => 20220193006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/552535
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552535 | COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS | Dec 15, 2021 | Pending |
Array
(
[id] => 17702760
[patent_doc_number] => 20220202766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/644069
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644069 | CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT | Dec 12, 2021 | Pending |
Array
(
[id] => 17503290
[patent_doc_number] => 20220096392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => EDDS CHELATED NANOCERIA WITH CATALASE-LIKE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/546640
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546640 | Edds chelated nanoceria with catalase-like activity | Dec 8, 2021 | Issued |
Array
(
[id] => 17685708
[patent_doc_number] => 20220193000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => KETAMINE TRANSDERMAL DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/540695
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540695 | KETAMINE TRANSDERMAL DELIVERY SYSTEM | Dec 1, 2021 | Abandoned |
Array
(
[id] => 18503554
[patent_doc_number] => 11701344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Bendamustine pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/532874
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 16314
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532874 | Bendamustine pharmaceutical compositions | Nov 21, 2021 | Issued |
Array
(
[id] => 18050619
[patent_doc_number] => 11523984
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-12-13
[patent_title] => Compositions and methods of administering baclofen
[patent_app_type] => utility
[patent_app_number] => 17/525298
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9750
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525298 | Compositions and methods of administering baclofen | Nov 11, 2021 | Issued |
Array
(
[id] => 19134591
[patent_doc_number] => 11969500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Implantable depots for the controlled release of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/454320
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 58
[patent_no_of_words] => 44934
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/454320 | Implantable depots for the controlled release of therapeutic agents | Nov 9, 2021 | Issued |
Array
(
[id] => 17519266
[patent_doc_number] => 20220105114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/499648
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499648 | METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS | Oct 11, 2021 | Pending |
Array
(
[id] => 19180995
[patent_doc_number] => 11987576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject
[patent_app_type] => utility
[patent_app_number] => 17/480948
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 40
[patent_no_of_words] => 13710
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480948 | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject | Sep 20, 2021 | Issued |